Schistosomiasis Impact Factor
Schistosomiasis, brought about by dioecious flatworms in the sort Schistosoma, is tormenting individuals from many creating nations these days and much of the time prompts extreme bleakness and mortality of the patients. Praziquantel based
chemotherapy and dismalness control for this
infection received as of now require suitable and proficient indicative advancements.
Schistosomiasis mansoni, referred to casually as bilharzia, came to Puerto Rico with the slave exchange [1-3]. Toward the start of the twentieth century,
schistosomiasis was restricted to a few low-commonness areas in Puerto Rico. The change from an espresso
economy sugarcane development and the ensuing development of huge scope water system frameworks, created monstrous movements of laborers from the mountains to the seaside areas .
Journals are known for their high
impact factor journals and a section of Group
journals are indexed in the world-renowned science database like Medline, PubMed Central, Obscure and Scopus.
Journals acquired as many as 40 reputed
journals such as
Schistosomiasis and others. As sugar development expanded did as well schistosomiasis.
Schistosomiasis is a contamination with one of a progression of related trematode parasites that are endemic to in any event 78 tropical and subtropical nations. More than 200 million individuals have this ailment; 120 million of them have side effects, 20 million have serious ailment and 600 million others stay in danger [5]. Four
species routinely contaminate the human host. Most of Schistosoma mansoni and Schistosoma haematobium contaminations are found in sub-Saharan Africa. Schistosoma mansoni stays endemic to parts of Brazil, Venezuela and the Caribbean. Schistosoma mekongi is found in Cambodia and Laos, along the Mekong River Delta. Schistosoma japonicum contamination happens in China, Indonesia and the Philippines
High Impact List of Articles
-
The next generation of trial design innovation: strategies, methods and logistical considerations for flexible trial designs
Terry L Katz, Sandeep Menon
Conference Report: Clinical Investigation
-
The next generation of trial design innovation: strategies, methods and logistical considerations for flexible trial designs
Terry L Katz, Sandeep Menon
Conference Report: Clinical Investigation
-
Everolimus for the treatment of advanced pancreatic neuroendocrine tumors
Paola Tomassetti, Monica Cevenini, Elena Guidetti, Giulia Cacciari, Maria Luigia Cipollini, Elena Galassi, Maria Camilla Fabbri, Francesca Nori, Davide Campana, Roberto Corinaldesi ,Roberto De Giorgio
Review: Clinical Trail Outcomes: Clinical Investigation
-
Everolimus for the treatment of advanced pancreatic neuroendocrine tumors
Paola Tomassetti, Monica Cevenini, Elena Guidetti, Giulia Cacciari, Maria Luigia Cipollini, Elena Galassi, Maria Camilla Fabbri, Francesca Nori, Davide Campana, Roberto Corinaldesi ,Roberto De Giorgio
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging clinical evidence in the treatment of eosinophilic esophagitis
CD Parmar , SE Attwood
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging clinical evidence in the treatment of eosinophilic esophagitis
CD Parmar , SE Attwood
Review: Clinical Trail Outcomes: Clinical Investigation
-
Investigational drug shows significant improvement in cancer survival rate
News and Views: Clinical Investigation
-
Investigational drug shows significant improvement in cancer survival rate
News and Views: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1
Thomas A Burrow, Gregory A Grabowski
Review Article: Clinical Investigation
-
Velaglucerase alfa in the treatment of Gaucher disease type 1
Thomas A Burrow, Gregory A Grabowski
Review Article: Clinical Investigation
Relevant Topics in Clinical